arrow
L

Linda N. Geng

stanford university school of medicine
H指数:27
被引数:4,248

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Low-Dose Aripiprazole for Long COVID Symptom Management: A Retrospective Observational Study

低剂量阿立哌唑用于长新冠症状管理:一项回顾性观察研究

2026-10-060
OAAI
Supporting the psychosocial well-being of patients with Long COVID: patient-informed strategies from a qualitative study

支持长新冠患者的心理社会福祉:一项定性研究中的患者知情策略

2026-09-240
OAAI
Plasma Extracellular Vesicle Surface Marker Profiling Reveals Immune Cell-Associated Mitochondrial Membrane Potential Alterations in Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

血浆外泌体表面标志物分析揭示长新冠和肌痛性脑脊髓炎/慢性疲劳综合征中与免疫细胞相关的线粒体膜电位改变

2026-05-010
PRE
Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19

经验性阿奇霉素改变了COVID-19患者上呼吸道微生物组和耐药组,但无抗炎益处。

2026-03-160
OAAI
Circulating endothelial signatures correlate with worse outcomes in COVID-19, respiratory failure and ARDS

循环内皮特征与COVID-19、呼吸衰竭和ARDS的不良结局相关。

2025-10-150
OAAI
Age-Related Changes in the Clinical Picture of Long COVID

长期COVID临床表现的年龄相关变化

2025-09-010
PRE
Differentiation of Prior SARS-CoV-2 Infection and Postacute Sequelae by Standard Clinical Laboratory Measurements in the RECOVER Cohort

通过恢复队列中的标准临床实验室测量来区分先前的SARS-CoV-2感染和急性后遗症

2024-09-014
PRE
Features of acute COVID-19 associated with post-acute sequelae of SARS-CoV-2 phenotypes: results from the IMPACC study

与SARS-CoV-2表型的急性后遗症相关的急性新型冠状病毒肺炎的特征: 来自IMPACC研究的结果

2024-01-0322
OAAI
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC) (vol 24, pg 1616, 2023)
2023-09-183
OA
SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)

新型冠状病毒肺炎急性后遗症 (PASC) 中的SARS-CoV-2水库

2023-09-0495
OA
Anti-nucleocapsid antibody levels and pulmonary comorbid conditions are linked to post-COVID-19 syndrome
2022-07-0824
OA